QuantuMDx: Jonathan O'Halloran, Neil Butler, Elaine Warburton, John Burn

Euformatics has named Tommi Kaasalainen as CEO. He replaces Olli Pasanen, who remains chairman of the Finnish genomic informatics firm. Kaasalainen joins Euformatics after serving as CEO of Nukute, a startup maker of wireless sensors for sleep apnea diagnostics. He also was executive VP of Innokas Medical, a medical device manufacturer in Finland.   

Inivata has appointed Peter Collins as the firm's chief business officer. Prior to Inivata, Collins most recently held senior leadership positions at Guardant Health. He has also served as chief business officer at Yourgene Health. Prior to Yourgene, Collins served as VP, head of diagnostics at GSK, as well as VP of pharma business development at Qiagen. He was also the founder and board member of Epemed. 

Edward Strong has been named scientific director of iAssay, a firm developing an open platform that consolidates utilization of a range of point-of-care tests with a single cloud-connected, handheld reader. Strong, a geneticist, formerly cofounded and served as CEO of MedGenomics, and also served as interim CEO of LifeGenomix.

Gravity Diagnostics has hired Mary Talbott as chief legal secretary and secretary. Talbott has more than 25 years of experience in corporate and private practice and most recently was senior vice president, general counsel, and corporate secretary for Tennant Company. Before that, she was VP, assistant general counsel, and assistant corporate secretary for General Cable. Gravity Dx is a full-service CLIA laboratory based in Covington, Kentucky and provides testing services in infectious diseases, toxicology, and pharmacogenomics.

NeoGenomics announced that Madhushree Ghosh has joined the company as VP of alliances and companion diagnostics. She previously served as the senior director of strategic accounts and global strategic partnerships at Thermo Fisher Scientific. She has also served as VP of alliance management and VP of the research services business unit at Althea Dx, as well as in senior leadership positions at Qiagen and Enigma Diagnostics. Ghosh has expertise in next-generation sequencing, multiplex and real-time PCR, oncology, and infectious diseases.

Joseph Holmes has been elected as VP and chief accounting officer of Thermo Fisher Scientific, effective March 31, 2021. He will succeed Peter Hornstra, who will retire from the company March 31. Holmes is currently senior director of technical accounting at Thermo Fisher, a position he assumed when he joined the company in 2017. Previously, he was director of technical accounting and reporting at St. Jude Medical, which was acquired by Abbott Laboratories in 2017.

Pacific Biosciences has appointed Susan Kim as CFO, effective Sept. 28, 2020. She brings 20 years of senior-level finance and operations experience. Kim most recently served as CFO for App Annie and Katerra. She has also held leadership roles at KLA Corporation, Morgan Stanley, and Advanced Micro Devices. Kim holds MBA and masters of engineering management degrees from Northwestern University.